Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice.

Gu B, Zhu M, Glass MR, Rougié M, Nikolova VD, Moy SS, Carney PR, Philpot BD.

J Clin Invest. 2019 Dec 2;129(12):5462-5467. doi: 10.1172/JCI130419.

2.

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.

Sonzogni M, Hakonen J, Bernabé Kleijn M, Silva-Santos S, Judson MC, Philpot BD, van Woerden GM, Elgersma Y.

Mol Autism. 2019 May 22;10:23. doi: 10.1186/s13229-019-0277-1. eCollection 2019.

3.

Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes.

Frohlich J, Miller MT, Bird LM, Garces P, Purtell H, Hoener MC, Philpot BD, Sidorov MS, Tan WH, Hernandez MC, Rotenberg A, Jeste SS, Krishnan M, Khwaja O, Hipp JF.

Biol Psychiatry. 2019 May 1;85(9):752-759. doi: 10.1016/j.biopsych.2019.01.008. Epub 2019 Jan 19.

4.

Subcellular organization of UBE3A in human cerebral cortex.

Burette AC, Judson MC, Li AN, Chang EF, Seeley WW, Philpot BD, Weinberg RJ.

Mol Autism. 2018 Oct 19;9:54. doi: 10.1186/s13229-018-0238-0. eCollection 2018.

5.

Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.

Gu B, Carstens KE, Judson MC, Dalton KA, Rougié M, Clark EP, Dudek SM, Philpot BD.

J Clin Invest. 2019 Jan 2;129(1):163-168. doi: 10.1172/JCI120816. Epub 2018 Nov 19.

6.

Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome.

Lee HM, Clark EP, Kuijer MB, Cushman M, Pommier Y, Philpot BD.

Mol Autism. 2018 Aug 17;9:45. doi: 10.1186/s13229-018-0228-2. eCollection 2018.

7.

The Temporal Dynamics of Arc Expression Regulate Cognitive Flexibility.

Wall MJ, Collins DR, Chery SL, Allen ZD, Pastuzyn ED, George AJ, Nikolova VD, Moy SS, Philpot BD, Shepherd JD, Müller J, Ehlers MD, Mabb AM, Corrêa SAL.

Neuron. 2018 Jun 27;98(6):1124-1132.e7. doi: 10.1016/j.neuron.2018.05.012. Epub 2018 May 31.

8.

Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG study.

den Bakker H, Sidorov MS, Fan Z, Lee DJ, Bird LM, Chu CJ, Philpot BD.

Mol Autism. 2018 Apr 27;9:32. doi: 10.1186/s13229-018-0214-8. eCollection 2018.

9.

Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome.

Sidorov MS, Judson MC, Kim H, Rougie M, Ferrer AI, Nikolova VD, Riddick NV, Moy SS, Philpot BD.

J Neurosci. 2018 Mar 14;38(11):2671-2682. doi: 10.1523/JNEUROSCI.2828-17.2018. Epub 2018 Feb 5.

10.

Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.

Thaxton C, Kloth AD, Clark EP, Moy SS, Chitwood RA, Philpot BD.

J Neurosci. 2018 Jan 24;38(4):918-936. doi: 10.1523/JNEUROSCI.1305-17.2017. Epub 2017 Dec 8.

11.

Long-Range GABAergic Inputs Regulate Neural Stem Cell Quiescence and Control Adult Hippocampal Neurogenesis.

Bao H, Asrican B, Li W, Gu B, Wen Z, Lim SA, Haniff I, Ramakrishnan C, Deisseroth K, Philpot B, Song J.

Cell Stem Cell. 2017 Nov 2;21(5):604-617.e5. doi: 10.1016/j.stem.2017.10.003.

12.

Distal axotomy enhances retrograde presynaptic excitability onto injured pyramidal neurons via trans-synaptic signaling.

Nagendran T, Larsen RS, Bigler RL, Frost SB, Philpot BD, Nudo RJ, Taylor AM.

Nat Commun. 2017 Sep 20;8(1):625. doi: 10.1038/s41467-017-00652-y.

13.

Enhanced Nociception in Angelman Syndrome Model Mice.

McCoy ES, Taylor-Blake B, Aita M, Simon JM, Philpot BD, Zylka MJ.

J Neurosci. 2017 Oct 18;37(42):10230-10239. doi: 10.1523/JNEUROSCI.1018-17.2017. Epub 2017 Sep 20.

14.

Erratum to: Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis.

Sidorov MS, Deck GM, Dolatshahi M, Thibert RL, Bird LM, Chu CJ, Philpot BD.

J Neurodev Disord. 2017 Jul 17;9:30. doi: 10.1186/s11689-017-9210-0. eCollection 2017.

15.

Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.

Judson MC, Burette AC, Thaxton CL, Pribisko AL, Shen MD, Rumple AM, Del Cid WA, Paniagua B, Styner M, Weinberg RJ, Philpot BD.

J Neurosci. 2017 Aug 2;37(31):7347-7361. doi: 10.1523/JNEUROSCI.0037-17.2017. Epub 2017 Jun 29.

16.

Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis.

Sidorov MS, Deck GM, Dolatshahi M, Thibert RL, Bird LM, Chu CJ, Philpot BD.

J Neurodev Disord. 2017 May 8;9:17. doi: 10.1186/s11689-017-9195-8. eCollection 2017. Erratum in: J Neurodev Disord. 2017 Jul 17;9:30.

17.

Ube3a loss increases excitability and blunts orientation tuning in the visual cortex of Angelman syndrome model mice.

Wallace ML, van Woerden GM, Elgersma Y, Smith SL, Philpot BD.

J Neurophysiol. 2017 Jul 1;118(1):634-646. doi: 10.1152/jn.00618.2016. Epub 2017 May 3.

18.

Subcellular organization of UBE3A in neurons.

Burette AC, Judson MC, Burette S, Phend KD, Philpot BD, Weinberg RJ.

J Comp Neurol. 2017 Feb 1;525(2):233-251. doi: 10.1002/cne.24063. Epub 2016 Jul 11.

19.

Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice.

Jones KA, Han JE, DeBruyne JP, Philpot BD.

Sci Rep. 2016 Jun 16;6:28238. doi: 10.1038/srep28238.

20.

Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms.

Mabb AM, Simon JM, King IF, Lee HM, An LK, Philpot BD, Zylka MJ.

PLoS One. 2016 May 27;11(5):e0156439. doi: 10.1371/journal.pone.0156439. eCollection 2016.

21.

Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex.

Kim H, Kunz PA, Mooney R, Philpot BD, Smith SL.

J Neurosci. 2016 Apr 27;36(17):4888-94. doi: 10.1523/JNEUROSCI.4204-15.2016.

22.

GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.

Judson MC, Wallace ML, Sidorov MS, Burette AC, Gu B, van Woerden GM, King IF, Han JE, Zylka MJ, Elgersma Y, Weinberg RJ, Philpot BD.

Neuron. 2016 Apr 6;90(1):56-69. doi: 10.1016/j.neuron.2016.02.040. Epub 2016 Mar 24.

23.

Loss of UBE3A from TH-expressing neurons suppresses GABA co-release and enhances VTA-NAc optical self-stimulation.

Berrios J, Stamatakis AM, Kantak PA, McElligott ZA, Judson MC, Aita M, Rougie M, Stuber GD, Philpot BD.

Nat Commun. 2016 Feb 12;7:10702. doi: 10.1038/ncomms10702.

24.

Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex.

Xing L, Larsen RS, Bjorklund GR, Li X, Wu Y, Philpot BD, Snider WD, Newbern JM.

Elife. 2016 Feb 5;5. pii: e11123. doi: 10.7554/eLife.11123.

25.

Rett Syndrome: Crossing the Threshold to Clinical Translation.

Katz DM, Bird A, Coenraads M, Gray SJ, Menon DU, Philpot BD, Tarquinio DC.

Trends Neurosci. 2016 Feb;39(2):100-113. doi: 10.1016/j.tins.2015.12.008. Review.

26.

Roles of Presynaptic NMDA Receptors in Neurotransmission and Plasticity.

Banerjee A, Larsen RS, Philpot BD, Paulsen O.

Trends Neurosci. 2016 Jan;39(1):26-39. doi: 10.1016/j.tins.2015.11.001. Epub 2015 Dec 23. Review.

27.

Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model.

Bruinsma CF, Schonewille M, Gao Z, Aronica EM, Judson MC, Philpot BD, Hoebeek FE, van Woerden GM, De Zeeuw CI, Elgersma Y.

J Clin Invest. 2015 Nov 2;125(11):4305-15. doi: 10.1172/JCI83541. Epub 2015 Oct 20.

28.

Maternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact.

Ehlen JC, Jones KA, Pinckney L, Gray CL, Burette S, Weinberg RJ, Evans JA, Brager AJ, Zylka MJ, Paul KN, Philpot BD, DeBruyne JP.

J Neurosci. 2015 Oct 7;35(40):13587-98. doi: 10.1523/JNEUROSCI.2194-15.2015.

29.

An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A.

Yi JJ, Berrios J, Newbern JM, Snider WD, Philpot BD, Hahn KM, Zylka MJ.

Cell. 2015 Aug 13;162(4):795-807. doi: 10.1016/j.cell.2015.06.045. Epub 2015 Aug 6.

30.

Gene length matters in neurons.

Zylka MJ, Simon JM, Philpot BD.

Neuron. 2015 Apr 22;86(2):353-5. doi: 10.1016/j.neuron.2015.03.059.

31.

Visual impairment in an optineurin mouse model of primary open-angle glaucoma.

Tseng HC, Riday TT, McKee C, Braine CE, Bomze H, Barak I, Marean-Reardon C, John SW, Philpot BD, Ehlers MD.

Neurobiol Aging. 2015 Jun;36(6):2201-12. doi: 10.1016/j.neurobiolaging.2015.02.012. Epub 2015 Feb 27.

32.

Socio-cultural disparities in GDM burden differ by maternal age at first delivery.

Abouzeid M, Versace VL, Janus ED, Davey MA, Philpot B, Oats J, Dunbar JA.

PLoS One. 2015 Feb 13;10(2):e0117085. doi: 10.1371/journal.pone.0117085. eCollection 2015.

33.

Transferable neuronal mini-cultures to accelerate screening in primary and induced pluripotent stem cell-derived neurons.

Niedringhaus M, Dumitru R, Mabb AM, Wang Y, Philpot BD, Allbritton NL, Taylor AM.

Sci Rep. 2015 Feb 10;5:8353. doi: 10.1038/srep08353.

34.

Topoisomerase 1 inhibition reversibly impairs synaptic function.

Mabb AM, Kullmann PH, Twomey MA, Miriyala J, Philpot BD, Zylka MJ.

Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17290-5. doi: 10.1073/pnas.1413204111. Epub 2014 Nov 17.

35.

A population-based observational study of diabetes during pregnancy in Victoria, Australia, 1999-2008.

Abouzeid M, Versace VL, Janus ED, Davey MA, Philpot B, Oats J, Dunbar JA.

BMJ Open. 2014 Nov 14;4(11):e005394. doi: 10.1136/bmjopen-2014-005394.

36.

Synapse-specific control of experience-dependent plasticity by presynaptic NMDA receptors.

Larsen RS, Smith IT, Miriyala J, Han JE, Corlew RJ, Smith SL, Philpot BD.

Neuron. 2014 Aug 20;83(4):879-93. doi: 10.1016/j.neuron.2014.07.039. Erratum in: Neuron. 2014 Sep 17;83(6);1481.

37.

Zylka et al. reply.

Zylka MJ, Philpot BD, King IF.

Nature. 2014 Aug 7;512(7512):E2. doi: 10.1038/nature13584. No abstract available.

38.

Snx14 regulates neuronal excitability, promotes synaptic transmission, and is imprinted in the brain of mice.

Huang HS, Yoon BJ, Brooks S, Bakal R, Berrios J, Larsen RS, Wallace ML, Han JE, Chung EH, Zylka MJ, Philpot BD.

PLoS One. 2014 May 23;9(5):e98383. doi: 10.1371/journal.pone.0098383. eCollection 2014.

39.

Scaling up diabetes prevention in Victoria, Australia: policy development, implementation, and evaluation.

Dunbar JA, Jayawardena A, Johnson G, Roger K, Timoshanko A, Versace VL, Shill J, Philpot B, Vartiainen E, Laatikainen T, Best JD, Janus ED.

Diabetes Care. 2014 Apr;37(4):934-42. doi: 10.2337/dc12-2647. Epub 2013 Dec 6.

PMID:
24319121
40.

Occupational differences, cardiovascular risk factors and lifestyle habits in South Eastern rural Australia.

Davis-Lameloise N, Philpot B, Janus ED, Versace VL, Laatikainen T, Vartiainen EA, Dunbar JA.

BMC Public Health. 2013 Nov 23;13:1090. doi: 10.1186/1471-2458-13-1090.

41.

Allelic specificity of Ube3a expression in the mouse brain during postnatal development.

Judson MC, Sosa-Pagan JO, Del Cid WA, Han JE, Philpot BD.

J Comp Neurol. 2014 Jun 1;522(8):1874-96. doi: 10.1002/cne.23507.

42.

Neuroprotective Sirtuin ratio reversed by ApoE4.

Theendakara V, Patent A, Peters Libeu CA, Philpot B, Flores S, Descamps O, Poksay KS, Zhang Q, Cailing G, Hart M, John V, Rao RV, Bredesen DE.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18303-8. doi: 10.1073/pnas.1314145110. Epub 2013 Oct 21.

43.

Topoisomerases facilitate transcription of long genes linked to autism.

King IF, Yandava CN, Mabb AM, Hsiao JS, Huang HS, Pearson BL, Calabrese JM, Starmer J, Parker JS, Magnuson T, Chamberlain SJ, Philpot BD, Zylka MJ.

Nature. 2013 Sep 5;501(7465):58-62. doi: 10.1038/nature12504. Epub 2013 Aug 28.

44.

A comparison of Australian rural and metropolitan cardiovascular risk and mortality: the Greater Green Triangle and North West Adelaide population surveys.

Tideman P, Taylor AW, Janus E, Philpot B, Clark R, Peach E, Laatikainen T, Vartiainen E, Tirimacco R, Montgomerie A, Grant J, Versace V, Dunbar JA.

BMJ Open. 2013 Aug 23;3(8):e003203. doi: 10.1136/bmjopen-2013-003203. Erratum in: BMJ Open. 2014 Mar 12;4(3):e003203corr1.

45.

Presynaptic NMDA receptor mechanisms for enhancing spontaneous neurotransmitter release.

Kunz PA, Roberts AC, Philpot BD.

J Neurosci. 2013 May 1;33(18):7762-9. doi: 10.1523/JNEUROSCI.2482-12.2013.

46.

Type 2 diabetes prevalence varies by socio-economic status within and between migrant groups: analysis and implications for Australia.

Abouzeid M, Philpot B, Janus ED, Coates MJ, Dunbar JA.

BMC Public Health. 2013 Mar 21;13:252. doi: 10.1186/1471-2458-13-252.

47.

The Melbourne Diabetes Prevention Study (MDPS): study protocol for a randomized controlled trial.

Davis-Lameloise N, Hernan A, Janus ED, Stewart E, Carter R, Bennett CM, O'Reilly S, Philpot B, Vartiainen E, Dunbar JA; Melbourne Diabetes Prevention Study (MDPS) research group.

Trials. 2013 Jan 31;14:31. doi: 10.1186/1745-6215-14-31.

48.

Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.

Huang HS, Burns AJ, Nonneman RJ, Baker LK, Riddick NV, Nikolova VD, Riday TT, Yashiro K, Philpot BD, Moy SS.

Behav Brain Res. 2013 Apr 15;243:79-90. doi: 10.1016/j.bbr.2012.12.052. Epub 2013 Jan 4.

49.

Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.

Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, Malanga CJ.

J Clin Invest. 2012 Dec;122(12):4544-54. doi: 10.1172/JCI61888. Epub 2012 Nov 12.

50.

Transsynaptic signaling by activity-dependent cleavage of neuroligin-1.

Peixoto RT, Kunz PA, Kwon H, Mabb AM, Sabatini BL, Philpot BD, Ehlers MD.

Neuron. 2012 Oct 18;76(2):396-409. doi: 10.1016/j.neuron.2012.07.006. Epub 2012 Oct 17. Erratum in: Neuron. 2012 Nov 8;76(3):667.

Supplemental Content

Loading ...
Support Center